1[1]Beatson GT. On the treatment of inoperable cases of carcinoma of the mannasuggestion for a new method of treatment with illustrative cases. Lancet, 18962104～107 被引量：1
2[2]Davidson NE. Ovarian ablation as treatment for young women with breast cancer.Inst. Monogr, 19941695～99 被引量：1
3[3]Locker GY. Hormonal therapy of breast cancer. Cancer Treatment Reviews, 199824221～240 被引量：1
4[4]Jensen EV DeSombre EB.＆Jungblut PW. Estrogen receptors in hormone-responsive tissues and tumors. In Wissler RWKao TLWood S Jr eds Endogenous Factors Influencing Host-Tumor Balance. Chicago IL University of Chicago Press196715～30 被引量：1
5[5]McGuire WL. Steroid receptors in human breast cancer. Cancer Res, 1978384289～4291 被引量：1
6[6]Jensen EV. Hormone dependency of breast cancer. Cancer,1981472319～2326 被引量：1
7[7]Leitzed R Teramoto Y Konrad K et al. Elevated c-erbB-2 antigen levels and decreased response to hormone therapy of breast cancer. J Clin Oncol, 1995131129～1135 被引量：1
8[8]Carlomagno C Perrone F Gallo C et al. CerbB-2 over-expression decreases the benefit of adjuvent tamoxifen in early-stage breast cancer without axillary node metastases. J Clin Oncol, 1996142702～2708 被引量：1
9[9]Soubeyran I Quenel N Coindre JM et al. pS2 proteina marker improving prediction of response to neoadjuvant tamoxifen in postmenopausal breast cancer. Br.J. Cancer,1996741120～1125 被引量：1
10[10]Early breast Cancer Trialists Collaborative Group.Tamoxifen for early breast canceran overview of the randomized trials.Lancet, 19983511451～1467 被引量：1
9Harris JR, Recht A, Gonnolly J, et al. Gonservative surgery and radiotherapy for early breast cancer [J]. Cancer, 1990, 66 (16):1427 - 1438 被引量：1
10Stemmer SM, Hardan Ⅰ, Raz H, et al. Adjrvant treatment of high-risk stage ⅡⅡ breast cancer with doxorubicin followed by high-dose chemotherapy and autoogous stem-cell transplantation a single-institution experience with 132 consecutive patients. Bone M 被引量：1
